Uremic toxins in the progression of chronic kidney disease and cardiovascular disease: mechanisms and therapeutic targets

YJ Lim, NA Sidor, NC Tonial, A Che, BL Urquhart - Toxins, 2021 - mdpi.com
Chronic kidney disease (CKD) is a progressive loss of renal function. The gradual decline in
kidney function leads to an accumulation of toxins normally cleared by the kidneys, resulting …

Atherosclerosis in chronic kidney disease: more, less, or just different?

JM Valdivielso, D Rodríguez-Puyol… - … , and vascular biology, 2019 - Am Heart Assoc
Patients with chronic kidney disease (CKD) are at an increased risk of premature mortality,
mainly from cardiovascular causes. The association between CKD on hemodialysis and …

Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions

LS Zhang, SS Davies - Genome medicine, 2016 - Springer
Mass spectrometry-and nuclear magnetic resonance-based metabolomic studies comparing
diseased versus healthy individuals have shown that microbial metabolites are often the …

Prognostic Value of Elevated Levels of Intestinal Microbe-Generated Metabolite Trimethylamine-N-Oxide in Patients With Heart Failure: Refining the Gut Hypothesis

WHW Tang, Z Wang, Y Fan, B Levison… - Journal of the American …, 2014 - jacc.org
Background: Altered intestinal function is prevalent in patients with heart failure (HF), but its
role in adverse outcomes is unclear. Objectives: This study investigated the potential …

The contributory role of gut microbiota in cardiovascular disease

WHW Tang, SL Hazen - The Journal of clinical investigation, 2014 - Am Soc Clin Investig
Our group recently discovered that certain dietary nutrients possessing a trimethylamine
(TMA) moiety, namely choline/phosphatidylcholine and L-carnitine, participate in the …

Intersections between microbiome and heart failure: revisiting the gut hypothesis

Y Nagatomo, WHW Tang - Journal of cardiac failure, 2015 - Elsevier
Microbes play an important role in human health and disease. In the setting of heart failure
(HF), substantial hemodynamic changes, such as hypoperfusion and congestion in the …

Impacts of indoxyl sulfate and p-cresol sulfate on chronic kidney disease and mitigating effects of AST-120

WC Liu, Y Tomino, KC Lu - Toxins, 2018 - mdpi.com
Uremic toxins, such as indoxyl sulfate (IS) and p-cresol, or p-cresyl sulfate (PCS), are
markedly accumulated in the organs of chronic kidney disease (CKD) patients. These toxins …

The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic …

M Sallée, L Dou, C Cerini, S Poitevin, P Brunet… - Toxins, 2014 - mdpi.com
Patients with chronic kidney disease (CKD) have a higher risk of cardiovascular diseases
and suffer from accelerated atherosclerosis. CKD patients are permanently exposed to …

Indoxyl sulfate, a uremic endotheliotoxin

G Lano, S Burtey, M Sallée - Toxins, 2020 - mdpi.com
Chronic kidney disease (CKD) is associated with a high prevalence of cardiovascular
diseases. During CKD, the uremic toxin indoxyl sulfate (IS)—derived from tryptophan …

Cardiotoxicity of uremic toxins: a driver of cardiorenal syndrome

S Lekawanvijit - Toxins, 2018 - mdpi.com
Cardiovascular disease (CVD) is highly prevalent in the setting of chronic kidney disease
(CKD). Such coexistence of CVD and CKD—the so-called “cardiorenal or renocardiac …